TuHURA Biosciences (HURA)

• Market cap: $141M
• 1 day: 4.74%
• 5 days: -2.64%
• 1 month: -3.49%
• 3 months: -0.45%
• 6 months: 249.91%
• Year to date: 194.86%
• 1 year: -20.5%
• 5 years: -99.92%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Employees: 22